Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect

scientific article published on January 1990

Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/0163-7258(90)90084-F
P698PubMed publication ID2203068

P2093author name stringDavis M
P433issue2
P921main subjectanxietyQ154430
P304page(s)147-165
P577publication date1990-01-01
P1433published inPharmacology & TherapeuticsQ3378596
P1476titleAnimal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect
P478volume47

Reverse relations

cites work (P2860)
Q404576385-Hydroxytryptamine pathways in anxiety and its treatment
Q60622978Acoustic startle in maltreated children
Q30412308Age- and sex-dependent effects of footshock stress on subsequent alcohol drinking and acoustic startle behavior in mice selectively bred for high-alcohol preference
Q30500018Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex
Q35407089Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing
Q51101232Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.
Q78052278Automated analysis of foot-shock sensitivity and concurrent freezing behavior in mice
Q90222366Autonomic responses to fear conditioning among women with PTSD and dissociation
Q36728468Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of corticotropin-releasing factor
Q36980075Behavioral measures of tinnitus in laboratory animals
Q44936841Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds
Q30480573CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues
Q57513867Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders
Q93216241Chronic inhibition of GABA synthesis in the infralimbic cortex facilitates conditioned safety memory and reduces contextual fear
Q28508341Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice
Q30464836Context, emotion, and the strategic pursuit of goals: interactions among multiple brain systems controlling motivated behavior.
Q48824455Differences in fear motivated behaviors among inbred mouse strains
Q52051168Differential acquisition of specific components of a classically conditioned arterial blood pressure response in rat.
Q40174485Differential acquisition, extinction, and reinstatement of conditioned suppression in mice.
Q37347970Differential effects of lorazepam on sleep and activity in C57BL/6J and BALB/cJ strain mice
Q27321760Effects of a Flavonoid-Rich Fraction on the Acquisition and Extinction of Fear Memory: Pharmacological and Molecular Approaches
Q34997419Effects of stressor predictability and controllability on sleep, temperature, and fear behavior in mice
Q30472672Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference
Q30377507Estrogen and extinction of fear memories: implications for posttraumatic stress disorder treatment.
Q36084337False context fear memory in rats
Q44377038Further evidence of an inverse genetic relationship between innate differences in alcohol preference and alcohol withdrawal magnitude in multiple selectively bred rat lines
Q37248304GABAergic antagonism of the central nucleus of the amygdala attenuates reductions in rapid eye movement sleep after inescapable footshock stress
Q47367059Genetic correlation between alcohol preference and conditioned fear: Exploring a functional relationship
Q50903339Genetic correlation between innate alcohol preference and fear-potentiated startle in selected mouse lines.
Q30478587Genetics of anxiety and trauma-related disorders
Q30475836Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses
Q30476607Impaired fear inhibition is a biomarker of PTSD but not depression
Q34062489Incubation of conditioned fear in the conditioned suppression model in rats: role of food-restriction conditions, length of conditioned stimulus, and generality to conditioned freezing.
Q30368948Individual Differences in Animal Stress Models: Considering Resilience, Vulnerability, and the Amygdala in Mediating the Effects of Stress and Conditioned Fear on Sleep
Q34117794Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety
Q36918176Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory
Q44071534Lead and conditioned fear to contextual and discrete cues
Q28484969Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice
Q33862518Measurement of anxiety in transgenic mice.
Q45267857Mild interoceptive stressors affect learning and reactivity to contextual cues: toward understanding the development of unexplained illnesses.
Q30474911Moderate recurrent hypoglycemia during early development leads to persistent changes in affective behavior in the rat.
Q48560852Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s
Q34510367Molecular pathways of anxiety revealed by knockout mice
Q36459652Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness
Q50781836Nesfatin-1 increases anxiety- and fear-related behaviors in the rat.
Q35132683Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder
Q51057187Neural plasticity and stress induced changes in defense in the rat.
Q28511234Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis
Q44086542Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala
Q30223910Not all stressors are equal: behavioral and endocrine evidence for development of contextual fear conditioning after a single session of footshocks but not of immobilization
Q30433061Origin and function of short-latency inputs to the neural substrates underlying the acoustic startle reflex
Q34539708Posttraumatic stress disorder in women: assessment and treatment in primary care
Q39015847Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors
Q34415600Retigabine: chemical synthesis to clinical application.
Q51107407Ritanserin facilitates anxiety in a simulated public-speaking paradigm.
Q41544963Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD.
Q45922543Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 mice.
Q26795477The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning
Q30462832The age of anxiety: role of animal models of anxiolytic action in drug discovery
Q36247092The ascent of mouse: advances in modelling human depression and anxiety
Q39211091The basolateral amygdala can mediate the effects of fear memory on sleep independently of fear behavior and the peripheral stress response
Q30413016The basolateral amygdala determines the effects of fear memory on sleep in an animal model of PTSD
Q35167484The defense system of fear: behavior and neurocircuitry
Q30446324Translational neuroscience measures of fear conditioning across development: applications to high-risk children and adolescents
Q34212336Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.

Search more.